Proteasome Inhibitor MG132 Enhances Sensitivity to Cisplatin on Ovarian Carcinoma Cells In Vitro and In Vivo | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Basic Science

Proteasome Inhibitor MG132 Enhances Sensitivity to Cisplatin on Ovarian Carcinoma Cells In Vitro and In Vivo

Online download statistics by month:

Online download statistics by month: February 2019 to January 2022

	Abstract	Full	Pdf
Feb 2019	4	0	0
Mar 2019	35	0	3
Apr 2019	20	0	0
May 2019	23	0	0
Jun 2019	44	0	2
Jul 2019	61	0	2
Aug 2019	18	0	0
Sep 2019	47	0	2
Oct 2019	40	0	2
Nov 2019	37	0	1
Dec 2019	46	0	0
Jan 2020	38	0	3
Feb 2020	24	0	1
Mar 2020	26	0	2
Apr 2020	81	0	1
May 2020	52	0	0
Jun 2020	44	0	2
Jul 2020	42	0	0
Aug 2020	34	0	0
Sep 2020	23	0	0
Oct 2020	16	0	0
Nov 2020	12	0	0
Dec 2020	23	0	0
Jan 2021	21	0	0
Feb 2021	8	0	2
Mar 2021	24	0	0
Apr 2021	24	0	2
May 2021	7	0	0
Jun 2021	3	0	0
Jul 2021	0	0	1
Oct 2021	18	0	2
Nov 2021	22	0	1
Dec 2021	42	0	1
Jan 2022	14	0	1
Total	973	0	31